Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: A prospective observational study

European Journal of Clinical Pharmacology

Volumn 69, Issue 9, 2013, Pages 1717-1724

  Marusic, Srecko ^a   Bacic Vrca, Vesna ^a   Obreli Neto, Paulo Roque ^b   Franic, Miljenko ^a   Erdeljic, Viktorija ^c   Gojo Tomic, Nives ^a  

^a University of Zagreb   (Croatia)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c KBC Zagreb   (Croatia)

Author keywords

Adverse drug reactions; Croatia; Diminished therapeutic effect; Drug drug interactions; Elderly patients

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IPRATROPIUM BROMIDE; IRON SALT; LAXATIVE; LEVOTHYROXINE; NITRATE; POTASSIUM CHLORIDE; PROPYLTHIOURACIL; PROTON PUMP INHIBITOR; SPIRONOLACTONE; SULFONYLUREA; THIAZIDE DIURETIC AGENT; WARFARIN;

ABDOMINAL PAIN; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASTHMA; BLEEDING; CONSTIPATION; CREATININE BLOOD LEVEL; DRUG ABSORPTION; DRUG DOSE REDUCTION; DRUG ELUTING STENT; DRUG INHIBITION; DRUG MONITORING; DRUG POTENTIATION; DRUG WITHDRAWAL; ELDERLY CARE; EPIGASTRIC PAIN; EPISTAXIS; FEMALE; FOLLOW UP; GASTRIC ULCER BLEEDING; GASTROINTESTINAL SYMPTOM; HEALTH CARE FACILITY; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INTERNAL MEDICINE; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; PATIENT SAFETY; POLYPHARMACY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SKIN BRUISING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; ULCEROGENESIS;

AGED; AGED, 80 AND OVER; CROATIA; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; OUTPATIENT CLINICS, HOSPITAL; PATIENT DISCHARGE; PROSPECTIVE STUDIES;

EID: 84882887932     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1531-7     Document Type: Article

References (46)

1. Hartshorn EA (2006) Drug interaction: 1. General considerations. Ann Pharmacother 40:116-118
2. Hines LE, Murphy JE (2011) Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9:364-377. doi: 10.1016/j.amjopharm.2011.10.004
3. Mallet L, Spinewine A, Huang A (2007) The challenge of managing drug interactions in elderly people. Lancet 370:185-191
4. Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48:133-143
5. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB, Pharmaceutical Care of the Elderly in Europe Research (PEER) Group (2002) Drug-drug interactions in the elderly. Ann Pharmacother 36:1675-1681
6. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH (2007) Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 16:641-651
7. Becker ML, Visser LE, van Gelder T, Hofman A, Stricker BH (2008) Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged ≥55 years. Drugs Aging 25:145-152
8. Magro L, Moretti U, Leone R (2012) Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Expert Opin Drug Saf 11:83-94
9. Mirosevic Skvrce N, Macolic Sarinic V, Mucalo I, Krnic D, Bozina N, Tomic S (2011) Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study. Croat Med J 52:604-614
10. Seymour RM, Routledge PA (1998) Important drug-drug interactions in the elderly. Drugs Aging 12:485-494
11. Gagne JJ, Maio V, Rabinowitz C (2008) Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 33:141-151
12. Lexi-Comp Online (2012) Lexi-Interact. Wolters Kluwer Health Clinical Solutions, Minneapolis. Available at: http://online.lexi.com/lco/action/ interact. Accessed 3 Aug 2012
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245
14. Macedo AF, Marques FB, Ribeiro CF, Teixeira F (2003) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 28:137-143
15. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, Khan A, van Walraven C (2004) Adverse events among medical patients after discharge from hospital. Can Med Assoc J 170:345-349
16. Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Welte T, Böger RH (2000) Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504-513
17. Bertoli R, Bissig M, Caronzolo D, Odorico M, Pons M, Bernasconi E (2010) Assessment of potential drug-drug interactions at hospital discharge. Swiss Med Wkly 140:w13043. doi: 10.4414/smw.2010.13043
18. Glintborg B, Andersen SE, Dalhoff K (2005) Drug-drug interactions among recently hospitalised patients - frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61:675-681
19. Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Da Cruz AN, Gaeti WP, Cuman RK (2012) Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the Brazilian primary public health system. J Pharm Pharm Sci 15:344-354
20. Astrand B, Astrand E, Antonov K, Petersson G (2006) Detection of potential drug interactions - a model for a national pharmacy register. Eur J Clin Pharmacol 62:749-756
21. Obreli-Neto PR, Nobili A, De Lyra Júnior DP, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Freitas AL, Tettamanti M, Gaeti WP, Cuman RK (2012) Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. J Pharm Pharm Sci 15:344-354
22. Glassman PA, Belperio P, Lanto A, Simon B, Valuck R, Sayers J, Lee M (2007) The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc 14:424-431
23. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Ménard JF, Bercoff E (1996) Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44:944-948
24. Lindley CM, Tully MP, Paramsothy V, Tallis RC (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21:294-300
25. Egger SS, Drewe J, Schlienger RG (2003) Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58:773-778
26. Bacic-Vrca V, Marusic S, Erdeljic V, Falamic S, Gojo-Tomic N, Rahelic D (2010) The incidence of potential drug-drug interactions in elderly patients with arterial hypertension. Pharm World Sci 32:815-821
27. Cusack BJ (2004) Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2:274-302
28. Perazella MA, Mahnensmith RL (1997) Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 12:646-656
29. Uijtendaal EV, Zwart-van Rijkom JE, van Solinge WW, Egberts TC (2011) Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs. Eur J Clin Pharmacol 67:933-940
30. Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC (2009) Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol 68:187-193
31. Iber FL, Murphy PA, Connor ES (1994) Age-related changes in the gastrointestinal system. Effects on drug therapy. Drugs Aging 5:34-48
32. Madanick RD (2011) Proton pump inhibitor side effects and drug interactions: much ado about nothing? Cleve Clin J Med 78:39-49
33. Sharma VR, Brannon MA, Carloss EA (2004) Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 97:887-889
34. Nutescu E, Chuatrisorn I, Hellenbart E (2011) Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 31:326-343
35. Cruciol-Souza JM, Thomson JC (2006) A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital. Clinics (Sao Paulo) 61:515-520
36. O'Neill JL, Remington TL (2003) Drug-induced esophageal injuries and dysphagia. Ann Pharmacother 37:1675-1684
37. Zarowitz BJ (2006) Oral solid potassium chloride and anticholinergic medications: a new drug interaction for an old drug? Geriatr Nurs 27:329-333
38. McMahon FG, Ryan JR, Akdamar K, Ertan A (1984) Effect of potassium chloride supplements on upper gastrointestinal mucosa. Clin Pharmacol Ther 35:852-855
39. Newton JL (2005) Effect of age-related changes in gastric physiology on tolerability of medications for older people. Drugs Aging 22:655-661
40. Siller-Matula JM, Lang I, Christ G, Jilma B (2008) Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 52:1557-1563
41. Good CW, Steinhubl SR, Brennan DM, Lincoff AM, Topol EJ, Berger PB (2012) Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Circ Cardiovasc Interv 5:77-81
42. Fulda TR, Valuck RJ, Vander Zanden J, Parker S, Byrns PJ (2000) Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr Ther Res 61:540-548
43. Vitry AI (2007) Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 63:709-714
44. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB (2003) Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc 44:136-141
45. Vonbach P, Dubied A, Krähenbühl S, Beer JH (2008) Evaluation of frequently used drug interaction screening programs. Pharm World Sci 30:367-374
46. Barrons R (2004) Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 61:380-385